Advanced Practice Providers: Therapeutic landscape & Novel Therapies for Myasthenia Gravis-Therapeutic landscape & Novel Therapies for Myasthenia Gravis

Therapeutic landscape & Novel Therapies for Myasthenia Gravis - Dr. Gil Wolfe

Video Transcription

Video Summary

Dr. Gil Wolfe, a neuromuscular specialist, presents a talk on therapeutic landscape and novel therapies for myasthenia gravis (MG). He discusses the prevalence and clinical features of MG, including muscle weakness, ptosis, diplopia, and respiratory weakness. Dr. Wolfe also highlights the advancements in MG therapies over time and the impact of thymectomy on remission rates. He then explores various treatment strategies, including B-cell therapies such as rituximab and complement-mediated agents like eculizumab. He explains their mechanisms of action and presents data from clinical trials to support their efficacy in MG. Additionally, he touches upon anti-FCRN and JAK-STAT blockers as potential treatment options. Dr. Wolfe concludes by mentioning the ongoing research and future directions in MG treatment.

Asset Caption

There are 3 questions in the Post Exam. Please use these questions to help test your knowledge after viewing the course. There is not a minimum score needed to pass.

Keywords

myasthenia gravis

muscle weakness

B-cell therapies

rituximab

complement-mediated agents

eculizumab

clinical trials

future directions